ArticleFrontiers in oncology2023

Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer: a real-world retrospective study in China.

Xiaoyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.